Non-medical switch from originator to biosimilar infliximab in patients with inflammatory arthritis: impact on s-infliximab and antidrug-antibodies. Results from the Danish Rheumatologic Biobank and the DANBIO registry

Bente Glintborg, Tina Kringelbach, Estrid Høgdall, Inge Juul Sørensen, Dorte Vendelbo Jensen, Anne Gitte Loft, Oliver Hendricks, Inger Marie Jensen Hansen, Nils Bolstad, David J. Warren, Johanna Gehin, Guro Goll, Kathrine Grøn, Grith Eng, Christian Enevold, Claus Henrik Nielsen, Julia S. Johansen, Merete L. Hetland

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
ArtikelnummerOP10
TidsskriftScandinavian Journal of Rheumatology
Vol/bind45
Udgave nummerSupplement 128
Sider (fra-til)6
Antal sider1
ISSN0300-9742
StatusUdgivet - 2016
Begivenhed36th Scandinavian Congress of Rheumatology - Harpa , Reykjavík, Island
Varighed: 1. sep. 20163. sep. 2016

Konference

Konference36th Scandinavian Congress of Rheumatology
LokationHarpa
LandIsland
ByReykjavík
Periode01/09/201603/09/2016

Citationsformater